2027 Express Scripts National Preferred Formulary

(continued)

DRUG CLASS

EXCLUDED MEDICATIONS

PREFERRED ALTERNATIVES

Immunosuppressant Agents

ENVARSUS XR

tacrolimus capsules methotrexate tablets

JYLAMVO, TREXALL, XATMEP

NIKTIMVO SOVUNA

IMBRUVICA, JAKAFI, JAKAFI XR

Inflammatory Conditions Agents Infused Non-TNF Biologics

hydroxychloroquine tablets

COSENTYX IV

COSENTYX SC

Infused Non-TNF Biologics - Tocilizumab Intravenous Agents

ACTEMRA IV, TOFIDENCE IV

AVTOZMA IV, TYENNE IV

Infused Non-TNF Biologics - Ustekinumab Agents OTULFI IV, PYZCHIVA IV, SELARSDI IV, STARJEMZA IV, STELARA IV, STEQEYMA IV, USTEKINUMAB IV, WEZLANA IV

IMULDOSA IV, USTEKINUMAB-TTWE IV (by Quallent), YESINTEK IV, ENTYVIO IV, OMVOH, SKYRIZI, TREMFYA

Infused TNF Antagonists Menkes Disease Agents

INFLECTRA, REMICADE, RENFLEXIS

AVSOLA, INFLIXIMAB

ZYCUBO

Coverage may be approved for the treatment of Menkes Disease under certain conditions. nitisinone 2mg capsules, NITYR 2 MG TABLETS Coverage may be approved for the treatment of Primary Hyperoxaluria Type 1 under certain conditions. Coverage may be approved for the treatment of Generalized Myasthenia Gravis.

Metabolic Agents

HARLIKU RIVFLOZA

Myasthenia Gravis Agents

IMAAVY, RYSTIGGO

ZILBRYSQ UPLIZNA

EPYSQLI

Neuromyelitis Optica Spectrum Disorder Agents NSAID and Acid Reducing Agent Combination Products

ENSPRYNG

ibuprofen/famotidine ibuprofen tablets plus famotidine tablets naproxen/esomeprazole magnesium, VIMOVO naproxen tablets, naproxen sodium tablets or naproxen ec tablets plus esomeprazole magnesium dr capsules

Osteoporosis (Bone Modifiers)

BOSAYA, CONEXXENCE, EVENITY, JUBBONTI, OSPOMYV (by Cordavis), PROLIA, STOBOCLO AUKELSO, BOMYNTRA, OSENVELT, WYOST, XGEVA

alendronate, ibandronate, risedronate, teriparatide, zoledronic acid, BILDYOS, ENOBY, TYMLOS

Other Bone Mineral Density Increasing Agents

BILPREVDA, XTRENBO

Potassium Replacement Agents Primary Biliary Cholangitis Agents Thymidine Kinase 2 Deficiency Agents

POKONZA, POTASSIUM CL 40MEQ PACKETS potassium chloride solution

LIVDELZI KYGEVVI

IQIRVO

Coverage may be approved for the treatment of Thymidine Kinase 2 Deficiency under certain conditions. liraglutide, FOUNDAYO, WEGOVY HD, WEGOVY PENS, WEGOVY TABLETS, ZEPBOUND PENS

Weight Loss

ZEPBOUND KWIKPENS, ZEPBOUND VIALS

Wilson’s Disease Agents

CUVRIOR, TRIENTINE 500MG CAPSULES

trientine 250mg capsules

© 2026 Evernorth Health Services. All rights reserved. All trademarks are the property of their respective owners. CRP1584203A 204612 NP Excl (08/01/2026)

Made with FlippingBook - professional solution for displaying marketing and sales documents online